Zobrazeno 1 - 10
of 134
pro vyhledávání: '"E, Verdy"'
Publikováno v:
Journal of Thrombosis and Haemostasis. 5:955-962
Summary. Background: Low-molecular-weight heparins (LMWHs), derived from unfractionated heparin (UFH) by different depolymerization procedures, vary in both their relative abilities to enhance the inhibition of FXa (anti-FXa) and thrombin (anti-FIIa)
Publikováno v:
Blood Coagulation and Fibrinolysis. 11:761-765
Variability of thrombotic disease among individuals homozygous for factor V Leiden has been described. It has been shown that some thrombotic patients carry an additional genetic risk factor such as protein C, protein S, antithrombin deficiency or th
Évaluation du risque thromboembolique avant stimulation ovarienne : quel bilan ? Quelle prévention ?
Autor:
E Verdy
Publikováno v:
Gynécologie Obstétrique & Fertilité. 28:875-879
The pathophysiology of thrombotic events remains unclear among women undergoing ovulation induction. In this review, present knowledge is summarized from the literature. Prospective studies are needed to determine risk factors and therapeutic approac
Publikováno v:
American Journal of Clinical Pathology. 112:233-237
To determine the real performance of the Agkistrodon contortrix venom (ACV) screening test for protein C (PC) pathway defects, we studied 400 consecutive patients referred for the study of personal venous thrombosis or for family study. All 82 patien
Publikováno v:
Clinical Infectious Diseases. 25:1159-1164
We conducted a study to assess the incidence and outcome of hemophagocytic histiocytosis (HH) in thrombocytopenic patients with sepsis syndrome or septic shock and to define the possible associations between HH, disseminated intravascular coagulation
Publikováno v:
Pathologie-biologie. 56(4)
Cancer is a real model of acquired hypercoagulable state. A close interaction exists between venous thromboembolic disease and cancer. Tumor progression is associated with an activation of coagulation and fibrinoformation which are both implicated in
Autor:
Muriel, Giansily-Blaizot, Régis, Verdier, Christine, Biron-Adréani, Jean-François, Schved, M A, Bertrand, J Y, Borg, V, Le Cam-Duchez, V, LeCam-Duchez, M E, Briquel, H, Chambost, K, Pouymayou, F, Dutrillaux, R, Favier, I, Martin-Toutain, E, Verdy, V, Gay, J, Goudemand, R, Navarro, A, Durin, R, d'Oiron, T, Lambert, G, Pernod, C, Barrot, J, Peynet, B, Bastenaire, P, Sie, N, Stieltjes, M F, Torchet, P, de Moerloose
Publikováno v:
Haematologica. 89(6)
Inherited factor VII (FVII) deficiency is a rare bleeding disorder characterized by a poor relationship between reported FVII clotting activity (FVII:C) and bleeding tendency. Our study was aimed at defining biological parameters that are possibly pr
Autor:
J P, Fagot, A, Flahault, M, Fodil, A, Kanfer, S, Alamowitch, J P, Haymann, I, Lecomte, H, Lioté, A, Parrot, J, Rossert, E, Verdy, A, Becker
Publikováno v:
Presse medicale (Paris, France : 1983). 30(5)
Low-molecular-weight heparins (LMWH) had official approval for use for venous thromboembolism prophylaxis only for surgery patients when this survey was conducted, but were nevertheless often used in non-surgery patients. We conducted this "before an
Autor:
E, Verdy
Publikováno v:
Gynecologie, obstetriquefertilite. 28(12)
The pathophysiology of thrombotic events remains unclear among women undergoing ovulation induction. In this review, present knowledge is summarized from the literature. Prospective studies are needed to determine risk factors and therapeutic approac
Autor:
J P, Fagot, A, Flahault, A, Kanfer, G, Benoit, A, Bellanger, O, Conort, I, Durand-Zaleski, H, Lioté, L, Mangin, J, Oliary, E, Verdy, A, Becker
Publikováno v:
Presse medicale (Paris, France : 1983). 29(1)
The efficiency of venous thromboembolism prophylaxis with low molecular weight heparins (LMWH) has not been established in non surgical patients, so their official preventive use has been limited in France since 1995 to surgery. However, a survey con